Growth Metrics

Bio-Rad Laboratories (BIO) Capital Expenditures Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -17.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 34.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -6.72%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.89%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -11.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -43.42%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 27.22%
10 Bio-Rad Laboratories 8.23 Bn 6.66 Bn 309.40 Mn -12.79%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.79%
Dec 31, 2025 6.76%
Sep 30, 2025 -21.14%
Jun 30, 2025 8.04%
Mar 31, 2025 -14.43%
Dec 31, 2024 1.50%
Sep 30, 2024 -8.78%
Jun 30, 2024 22.12%
Mar 31, 2024 12.53%
Dec 31, 2023 21.41%
Sep 30, 2023 59.82%
Jun 30, 2023 99.83%
Mar 31, 2023 8.00%
Dec 31, 2022 -38.04%
Sep 30, 2022 -20.37%
Jun 30, 2022 -25.89%
Mar 31, 2022 69.22%
Dec 31, 2021 14.94%
Sep 30, 2021 73.33%
Jun 30, 2021 29.10%
Mar 31, 2021 -9.47%
Dec 31, 2020 126.31%
Sep 30, 2020 -35.74%
Jun 30, 2020 -18.45%
Mar 31, 2020 -8.62%
Dec 31, 2019 -83.36%
Jun 30, 2019 181.73%
Mar 31, 2019 -13.08%
Dec 31, 2018 398.01%
Jun 30, 2018 -216.43%
Mar 31, 2018 -63.04%
Dec 31, 2017 -81.57%
Jun 30, 2017 10.78%
Mar 31, 2017 663.35%
Dec 31, 2016 405.34%
Jun 30, 2016 60.69%
Mar 31, 2016 -64.42%
Dec 31, 2015 2,750.00%
Sep 30, 2015 4,880.06%
Jun 30, 2015 -226.05%
Mar 31, 2015 19.92%
Dec 31, 2014 -96.46%
Sep 30, 2014 -91.96%
Jun 30, 2014 -20.68%
Mar 31, 2014 -33.79%
Dec 31, 2013 -9.12%
Sep 30, 2013 -44.53%
Jun 30, 2013 -40.32%
Mar 31, 2013 -1.59%
Dec 31, 2012 -14.45%
Sep 30, 2012 48.60%
Jun 30, 2012 65.84%
Mar 31, 2012 94.59%
Dec 31, 2011 10.77%
Sep 30, 2011 21.01%
Jun 30, 2011 -52.67%
Mar 31, 2011 208.53%
Dec 31, 2010 -72.48%
Sep 30, 2010 231.26%